Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter Kinney

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
Vaccine|December 4, 2012
Introduction of human papillomavirus DNA screening in the world: 15 years of experiencePhilip E Castle, Silvia de Sanjosé, You-Lin Qiao, et al.
JAMA Oncology|July 25, 2024
Population-Based Incidence of Cervical Intraepithelial Neoplasia Across 14 Years of HPV VaccinationRachael Adcock, Huining Kang, Philip E Castle, et al.
Obstetrics and Gynecology|January 9, 2003
Screening interval and risk of invasive squamous cell cervical cancerMarie Grisham Miller, Hai-Yen Sung, George F Sawaya, et al.
Acta Cytologica|August 30, 2005
Cervical cancer after multiple negative cytologic tests in long-term members of a prepaid health planGeorge F Sawaya, Hai-Yen Sung, Walter Kinney, et al.
Obstetrics and Gynecology|February 24, 2011
Variable risk of cervical precancer and cancer after a human papillomavirus-positive testPhilip E Castle, Barbara Fetterman, Nancy Poitras, et al.
Journal of the National Cancer Institute|June 3, 2024
Primary human papillomavirus testing vs cotesting: clinical outcomes in populations with different disease prevalenceShrutikona Das, Nicolas Wentzensen, George F Sawaya, et al.
Journal of Lower Genital Tract Disease|December 31, 2010
Risk of cervical precancer and cancer in women aged 30 years and older with an HPV-negative low-grade squamous intraepithelial lesion screening resultRamey D Littell, Walter Kinney, Barbara Fetterman, et al.
Gynecologic Oncology|May 26, 2009
Age-appropriate use of human papillomavirus vaccines in the U.SPhilip E Castle, Barbara Fetterman, Israh Akhtar, et al.
Journal of the National Cancer Institute|December 30, 2015
ResponseNicolas Wentzensen, Barbara Fetterman, Philip Castle, et al.
Journal of Virological Methods|February 7, 2013
A study of borderline positive Hybrid Capture 2 tests in the Kaiser Permanente Northern California cervical screening program: evidence against retestingBrandon J Lamere, Philip E Castle, Barbara Fetterman, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Vaccine|December 4, 2012
Introduction of human papillomavirus DNA screening in the world: 15 years of experiencePhilip E Castle, Silvia de Sanjosé, You-Lin Qiao, et al.
JAMA Oncology|July 25, 2024
Population-Based Incidence of Cervical Intraepithelial Neoplasia Across 14 Years of HPV VaccinationRachael Adcock, Huining Kang, Philip E Castle, et al.
Obstetrics and Gynecology|January 9, 2003
Screening interval and risk of invasive squamous cell cervical cancerMarie Grisham Miller, Hai-Yen Sung, George F Sawaya, et al.
Acta Cytologica|August 30, 2005
Cervical cancer after multiple negative cytologic tests in long-term members of a prepaid health planGeorge F Sawaya, Hai-Yen Sung, Walter Kinney, et al.
Obstetrics and Gynecology|February 24, 2011
Variable risk of cervical precancer and cancer after a human papillomavirus-positive testPhilip E Castle, Barbara Fetterman, Nancy Poitras, et al.
Journal of the National Cancer Institute|June 3, 2024
Primary human papillomavirus testing vs cotesting: clinical outcomes in populations with different disease prevalenceShrutikona Das, Nicolas Wentzensen, George F Sawaya, et al.
Journal of Lower Genital Tract Disease|December 31, 2010
Risk of cervical precancer and cancer in women aged 30 years and older with an HPV-negative low-grade squamous intraepithelial lesion screening resultRamey D Littell, Walter Kinney, Barbara Fetterman, et al.
Gynecologic Oncology|May 26, 2009
Age-appropriate use of human papillomavirus vaccines in the U.SPhilip E Castle, Barbara Fetterman, Israh Akhtar, et al.
Journal of the National Cancer Institute|December 30, 2015
ResponseNicolas Wentzensen, Barbara Fetterman, Philip Castle, et al.
Journal of Virological Methods|February 7, 2013
A study of borderline positive Hybrid Capture 2 tests in the Kaiser Permanente Northern California cervical screening program: evidence against retestingBrandon J Lamere, Philip E Castle, Barbara Fetterman, et al.
Pageof 6